Skip to content
Disclosery

ORBIMED ADVISORS LLC: ARGX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on ARGX, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 92,880 ARGX shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 92,880 shares
    Change vs previous 13F -44,020 shares

    1.63% of the 13F portfolio, value $86,171,278.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 136,900 shares
    Change vs previous 13F -9,100 shares

    2.18% of the 13F portfolio, value $99,971,225.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 146,000 shares
    Change vs previous 13F -26,300 shares

    2.51% of the 13F portfolio, value $122,778,700.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 172,300 shares
    Change vs previous 13F -35,700 shares

    3.05% of the 13F portfolio, value $127,081,588.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 208,000 shares
    Change vs previous 13F +1,300 shares

    2.88% of the 13F portfolio, value $114,653,760.

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 206,700 shares
    Change vs previous 13F +17,000 shares

    2.94% of the 13F portfolio, value $122,338,496.

    13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 189,700 shares
    Change vs previous 13F -14,800 shares

    2.42% of the 13F portfolio, value $116,665,500.

    13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 204,500 shares
    Change vs previous 13F not available

    2.03% of the 13F portfolio, value $110,855,360.

    13F-HR 0001172661-24-005167 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).